文献速递细菌感染、耐药与抗菌药物医院感染防控

实验室衰弱指数(FI-Lab)预测院内耐碳青霉烯类肺炎克雷伯菌血流感染不良结局

Frailty Index Laboratory (FI-Lab) as predictor of poor outcomes for intra-hospital multidrug-resistant Klebsiella pneumoniae bloodstream infections: a single-centre retrospective cohort study.
PubMed 文献 · J Antimicrob Chemother · 2025-01-01

本研究为单中心回顾性队列研究,纳入2020年1月至2024年9月巴里大学医院182例耐碳青霉烯类肺炎克雷伯菌血流感染患者,采用入院96小时内35项实验室参数计算的FI-Lab评估衰弱。结果显示FI-Lab对全因死亡、28天死亡和复发的预测AUC分别为0.94、0.87和0.87,FI-Lab每增加0.10分,死亡风险HR为2.07。

要点

  • FI-Lab可早期识别CR-Kp血流感染中的衰弱患者,预测死亡和复发。
  • FI-Lab对全因死亡的预测AUC达0.94,28天死亡和复发AUC均为0.87。
  • FI-Lab每升高0.10分,死亡风险HR为2.07,28天死亡HR为1.86,复发HR为1.52。

核心结论

  • FI-Lab是CR-Kp血流感染患者早期衰弱评估的简单且稳健的工具,可预测不良结局。

研究设计与样本

  • 单中心回顾性队列研究,2020年1月至2024年9月于巴里大学医院纳入182例CR-Kp血流感染患者。
  • 衰弱评估采用基于入院96小时内35项实验室参数的FI-Lab,通过ROC曲线分析预测准确性。

主要发现

  • 182例患者中48例死亡,占26.3%。
  • 非幸存者FI-Lab评分显著高于幸存者(0.66 ± 0.10 对 0.33 ± 0.16,P < 0.0001)。
  • FI-Lab对全因死亡预测AUC为0.94,对28天死亡预测AUC为0.87,对复发预测AUC为0.87。
  • FI-Lab每增加0.10分,死亡风险HR为2.07,28天死亡风险HR为1.86,复发风险HR为1.52。

临床怎么用

  • 入院早期可计算FI-Lab以识别CR-Kp血流感染中的衰弱高危患者,辅助临床决策。

局限性

  • 单中心回顾性设计,结果需进一步多中心研究验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVES: Bloodstream infections (BSIs) caused by carbapenemase-resistant Klebsiella pneumoniae (CR-Kp) are associated with high morbidity and mortality, particularly in frail patients. Identifying frailty upon hospital admission may improve clinical decision-making and outcomes. This study evaluates the Frailty Index Laboratory (FI-Lab) as a predictive tool for adverse outcomes in patients with CR-Kp BSIs. METHODS: This retrospective cohort study was conducted between January 2020 and September 2024 at the Policlinico Universitario di Bari. Frailty was assessed using FI-Lab, derived from 35 laboratory parameters measured within 96 h of admission. Outcomes included all-cause mortality, 28 day mortality and relapse, with FI-Lab predictive accuracy evaluated via ROC curve analysis. RESULTS: A total of 182 patients with CR-Kp BSIs were included, of whom 48 died (26.3%). Non-survivors had significantly higher FI-Lab scores than survivors (0.66 ± 0.10 versus 0.33 ± 0.16, P < 0.0001). FI-Lab demonstrated excellent predictive accuracy for mortality (AUC = 0.94), 28 day mortality (AUC = 0.87) and relapse (AUC = 0.87). Each 0.10-point increase in FI-Lab was associated with a higher risk of mortality (HR = 2.07), 28 day mortality (HR = 1.86) and relapse (HR = 1.52). CONCLUSIONS: The FI-Lab proved to be a simple and robust tool for early frailty assessment in patients with CR-Kp BSIs. Further studies are needed to validate these findings and explore the broader applicability of FI-Lab in managing infections in vulnerable populations.

来源:J Antimicrob Chemother,查看原文。版权归原作者所有。

引用

  1. Pellegrino C, Veronese N, De Santis L, et al. Frailty Index Laboratory (FI-Lab) as predictor of poor outcomes for intra-hospital multidrug-resistant Klebsiella pneumoniae bloodstream infections: a single-centre retrospective cohort study. J Antimicrob Chemother. 2025. PMID: 41054943. doi:10.1093/jac/dkaf359

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。